Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model

Background: Chemotherapy is the backbone of systemic treatment for triple negative breast cancer (TNBC), which is one of the most relevant breast cancers molecular types due to the ability of tumor cells to develop drug resistance, highlighting the urgent need to design newer and safer drug combinat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: García-Castillo, Verónica, López-Urrutia, Eduardo, Villanueva-Sánchez, Octavio, Ávila-Rodríguez, Miguel Á., Zentella-Dehesa, Alejandro, Cortés-González, Carlo, López-Camarillo, César, Jacobo-Herrera, Nadia J, Pérez-Plasencia, Carlos
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327367/
https://ncbi.nlm.nih.gov/pubmed/28243322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.16387
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires